Exciting news for patients managing obesity! The National Institute for Health and Care Excellence (NICE) formally launched its guidance for the weight loss drug Tirzepatide on 23 December 2024. This ground-breaking treatment will be available for adults aged 18 and over who: Have obesity (BMI over 35), and Have at least one weight-related health condition….
New Weight Loss Medication, Tirzepatide, Launched December 2024
